RadNet, Inc.
RDNT
Classificação em ações
#3236
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Preço da ação
$69.56
Última sincronização: 2026-10-19
Valor de mercado
$5.47B
Variação (1 dia)
1.10%
Variação (1 ano)
-11.33%
País
US
Negociar RadNet, Inc. (RDNT)
Categoria
Healthcare
Lucros da RadNet, Inc. (RDNT)
Lucros em Jun 2026 TTM: $34.98M
De acordo com os últimos relatórios financeiros da RadNet, Inc., os ganhos atuais da empresa são de $34.98M. Em 2023, a empresa teve ganhos de $38.81M, uma diminuição em relação a aos ganhos de 2022, que foram de $42.97M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da RadNet, Inc. de 2000 a 2026
Lucros no final de cada ano
| Ano | Lucros | Alterar |
|---|---|---|
| 2026 (TTM) | $34.98M | -22.03% |
| 2024 | $44.86M | 15.59% |
| 2023 | $38.81M | -9.68% |
| 2022 | $42.97M | -27.02% |
| 2021 | $58.88M | -6,994.50% |
| 2020 | $-854.00K | -102.88% |
| 2019 | $29.67M | -22.99% |
| 2018 | $38.53M | 46.02% |
| 2017 | $26.39M | 112.17% |
| 2016 | $12.44M | -15.08% |
| 2015 | $14.65M | 301.01% |
| 2014 | $3.65M | -37.95% |
| 2013 | $5.89M | -380.42% |
| 2012 | $-2.10M | -171.44% |
| 2011 | $2.94M | -114.45% |
| 2010 | $-20.34M | 99.64% |
| 2009 | $-10.19M | -46.58% |
| 2008 | $-19.07M | 5.18% |
| 2007 | $-18.13M | 163.00% |
| 2006 | $-6.89M | 119.90% |
| 2005 | $-3.14M | -66.44% |
| 2004 | $-9.34M | 74.17% |
| 2003 | $-5.36M | 3.83% |
| 2002 | $-5.17M | -156.26% |
| 2001 | $9.18M | -36.69% |
| 2000 | $14.50M | 0.00% |
Lucros de empresas semelhantes ou concorrentes
| Empresa | Lucros | Diferença de Lucros | País |
|---|---|---|---|
| $7.61B | 21,653.05% |
US
|
|
| $4.76B | 13,513.88% |
US
|
|
| $-252.70M | -822.44% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 4,639.99% |
US
|
